![]() |
市場調查報告書
商品編碼
1954664
全球按鈕式安全採血針市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察及預測(2026-2034)Button-activated Safety Lancet Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球按鈕式安全採血針市場規模為7.547億美元,預計2026年將成長至8.4024億美元。到2034年,該市場預計將達到21.1711億美元,預測期內年複合成長率(CAGR)為12.25%。
2025年,北美以57.70%的市場佔有率引領全球市場。該地區的領先地位得益於其糖尿病的高發病率、完善的醫療保健基礎設施以及即時診斷(POC)技術的廣泛應用。
按鈕式安全採血針是一種拋棄式裝置,用於快速刺穿皮膚以採集毛細血管血液樣本。只需按下位於頂部或側面的按鈕即可活化,可伸縮的針頭或刀片隨即伸出,最大限度地減少針刺傷和交叉感染。它們廣泛用於血糖監測、血紅蛋白檢測、膽固醇篩檢和其他診斷應用。
市場動態
市場驅動因素
糖尿病盛行率上升和即時檢測成長
全球糖尿病負擔日益加重是市場擴張的主要驅動因素。頻繁的血糖監測需要安全、衛生且易於使用的採血針,尤其是在家庭醫療保健環境中。根據國際糖尿病聯盟(IDF)的預測,到2050年,非洲糖尿病患者人數預計將達到 6,000萬,比2024年增加 142%。
此外,即時診斷設備的日益普及也推動了市場需求。按鈕式安全採血針通常與血糖儀和攜帶式分析儀搭配使用。農村地區醫療保健服務的普及以及疾病早期檢測工作的推進,進一步加速了該產品的推廣應用。
市場限制因子
替代採血技術的興起
持續血糖監測(CGM)系統的日益普及給傳統採血針的使用帶來了挑戰。持續血糖監測(CGM)設備無需頻繁紮手指即可提供即時血糖資料,減少對採血針的依賴。
例如,2021年 11月,Intuity Medical 在美國推出了 Pogo 自動血糖監測系統,無需單獨購買試紙和採血針。隨著微創技術價格的下降,其廣泛應用可能會限制傳統安全採血針的長期成長。
市場機會
家庭診斷需求不斷增加
向家庭醫療保健和遠距患者監測的轉變帶來了強勁的成長機會。疫情之後,老年人和慢性病患者越來越傾向於在家管理自身病情。
根據美國國家生物技術資訊中心(NCBI)於2022年 8月發布的一項研究,加拿大安大略省 80 歲及以上人群的居家血糖檢測率從2013年的70%上升至約 80%。按鈕式安全採血針以其符合人體工學的設計和易用性而聞名,是滿足此需求的理想產品。
市場挑戰
認知度低且使用不當
在低收入和中等收入國家,認知度低和使用不當阻礙了採血針的普及。操作不當、試圖重複使用以及處置不當都會危及安全。此外,不同品牌採血針的針號和工作壓力缺乏標準化,也造成了使用者困擾。
市場趨勢
超細規格採血針需求成長
市場對超細規格(28G以上)採血針的需求強勁,目的是減輕疼痛並提高患者舒適度。這些產品尤其受到兒童和老年人的歡迎。
製造商正致力於人體工學設計、直觀的操作系統、顏色編碼的穿刺深度指示器以及改進的包裝,以方便消毒和處置。隨著門診護理和遠距醫療服務的擴展,對易於使用的設備的需求持續成長。
依產品類型
市場分為按壓式/頂部按鈕式和側邊按鈕式採血針。
2024年,按壓式/頂部按鈕式採血針因其操作簡便且與血糖儀相容而佔據市場主導地位。預計側邊按鈕式採血針由於能夠更佳控制穿刺深度並減輕手部疲勞,將顯著提高其年複合成長率。
依切口類型
市場分為針型和刀片型。
2024年,針型採血針因其疼痛感較低、穿刺力較小而佔據市場主導地位。刀片式採血針佔據第二大市場佔有率,因其更高的樣本採集率而受到實驗室的青睞。
依年齡組別劃分
2024年,成人市場佔據主導地位,這主要得益於慢性病的高發生率。由於青少年糖尿病病例的增加和學校健康篩檢計劃的推進,預計兒童市場將保持穩定成長。
依應用領域劃分
2024年,血糖監測領域佔據最大市場佔有率,這主要得益於糖尿病發生率的上升和家庭檢測需求的成長。隨著貧血篩檢計畫的增加,血紅素檢測的需求也在增加。
依規格劃分
2024年,28G以上規格的採血針因其疼痛感更輕、癒合更快而佔據市場主導地位。在臨床實務中,22G細分市場佔據第二大佔有率。
依通路劃分
到2024年,由於醫院藥局的大量採購,其市場佔有率最大。由於電子商務滲透率的不斷提高,預計線上藥局將實現最高的年複合成長率。
北美
北美地區憑藉其完善的健保體系和較高的自我監測率,將繼續保持其區域主導地位,到2025年市場規模達到2.637億美元,到2026年將達到2.9197億美元。
歐洲
在對老年護理和數位醫療的投資支持下,歐洲預計將保持穩定成長。
亞太地區
預計到2034年,亞太地區將實現最高的年複合成長率,這主要得益於中國和印度糖尿病患病率的上升。
拉丁美洲和中東及非洲
預計拉丁美洲將實現顯著成長,由於醫療保健服務的改善,預計中東和非洲地區將逐步擴張。
The global button-activated safety lancet market size was valued at USD 754.7 million in 2025 and is projected to grow to USD 840.24 million in 2026. The market is expected to reach USD 2,117.11 million by 2034, registering a CAGR of 12.25% during the forecast period.
North America dominated the global market with a 57.70% share in 2025. The region's leadership is driven by a high prevalence of diabetes, strong healthcare infrastructure, and widespread adoption of point-of-care (POC) diagnostics.
Button-activated safety lancets are single-use devices designed to obtain capillary blood samples through a quick skin puncture. Activated by a push/top or side-positioned button, these devices trigger a retractable needle or blade to minimize needlestick injuries and cross-contamination. They are widely used for blood glucose monitoring, hemoglobin testing, cholesterol screening, and other diagnostic applications.
Market Dynamics
Market Drivers
Rising Diabetes Prevalence and Growth of Point-of-Care Testing
The growing global burden of diabetes is a major driver of market expansion. Frequent blood glucose monitoring requires safe, hygienic, and easy-to-use lancets, particularly in home-care settings. According to the International Diabetes Federation, diabetes prevalence in Africa is projected to reach 60 million by 2050, reflecting a 142% increase compared to 2024 levels.
Additionally, the increasing use of point-of-care diagnostic devices has strengthened demand. Button-activated safety lancets are commonly paired with glucometers and portable analyzers. Expanding rural healthcare access and early disease detection initiatives are further accelerating product adoption.
Market Restraints
Emergence of Alternative Blood Sampling Technologies
The growing adoption of continuous glucose monitoring (CGM) systems poses a challenge to traditional lancet usage. CGM devices provide real-time glucose data without frequent finger pricks, reducing reliance on lancets.
For instance, in November 2021, Intuity Medical launched the Pogo Automatic Blood Glucose Monitoring System in the U.S., eliminating the need for separate strips and lancets. As prices of minimally invasive technologies decline, their adoption may limit the long-term growth of conventional safety lancets.
Market Opportunities
Expanding Demand for Home-Based Diagnostics
The shift toward home healthcare and remote patient monitoring presents strong growth opportunities. Post-pandemic, elderly and chronic patients increasingly prefer managing conditions at home.
A study published on NCBI in August 2022 reported that home glucose testing among individuals aged over 80 years in Ontario, Canada, increased to approximately 80%, compared to 70% in 2013. Button-activated safety lancets, known for ergonomic design and ease of use, are well-positioned to meet this demand.
Market Challenges
Limited Awareness and Improper Usage
In low- and middle-income countries, limited awareness and improper handling practices hinder adoption. Incorrect activation, reuse attempts, or improper disposal can compromise safety. Additionally, lack of standardization in gauge sizes and activation pressures across brands creates confusion among users.
Market Trends
Rising Preference for Ultra-Fine Gauge Lancets
The market is witnessing strong demand for ultra-fine gauge sizes (above 28G) to reduce pain and enhance patient comfort. These variants are particularly popular among pediatric and geriatric populations.
Manufacturers are focusing on ergonomic designs, intuitive activation systems, color-coded depth indicators, and improved packaging for sterility and ease of disposal. As outpatient care and telehealth services expand, demand for user-friendly devices continues to rise.
By Product Type
The market is segmented into push/top button and side button lancets.
The push/top button segment dominated in 2024 due to ease of use and compatibility with glucometers. The side button segment is projected to register a considerable CAGR owing to improved control over puncture depth and reduced hand strain.
By Incision Type
The market is divided into needle and blade.
The needle segment dominated in 2024 due to reduced pain and low penetration force. Blade lancets hold the second-largest share, preferred in laboratories for higher sample yield.
By Age Group
The adult segment dominated in 2024, driven by high prevalence of chronic diseases. The pediatric segment is projected to grow steadily due to rising juvenile diabetes cases and school screening initiatives.
By Application
The blood glucose monitoring segment held the largest share in 2024, supported by rising diabetes incidence and home-based testing demand. Hemoglobin testing is also growing due to increasing anemia screening programs.
By Gauge Size
Lancets above 28G dominated the market in 2024 due to minimal pain and faster healing. The 22G segment held the second-largest share in clinical settings.
By Distribution Channel
Hospital pharmacies accounted for the largest share in 2024 due to bulk procurement. Online pharmacies are expected to register the highest CAGR owing to growing e-commerce penetration.
North America
North America was valued at USD 263.7 million in 2025 and USD 291.97 million in 2026, maintaining regional dominance due to strong reimbursement systems and high self-monitoring adoption.
Europe
Europe is projected to grow steadily, supported by investments in elderly care and digital health.
Asia Pacific
Asia Pacific is expected to witness the highest CAGR through 2034, driven by rising diabetes prevalence in China and India.
Latin America and Middle East & Africa
Latin America is projected to grow significantly, while the Middle East & Africa is expected to experience moderate expansion due to improving healthcare access.
Competitive Landscape
Key players include:
Companies are focusing on product innovation and capacity expansion. In January 2025, BD expanded investments in its U.S. manufacturing network to enhance production of essential medical devices.
Conclusion
The global button-activated safety lancet market, valued at USD 754.7 million in 2025, is projected to grow to USD 840.24 million in 2026 and reach USD 2,117.11 million by 2034, expanding at a CAGR of 12.25%. Growth is driven by rising diabetes prevalence, increasing point-of-care diagnostics, and expanding home-based healthcare adoption. While alternative technologies such as CGM systems present challenges, ongoing product innovation and growing healthcare access in emerging markets are expected to sustain strong market growth through 2034.
Segmentation By Product Type, Incision Type, Age Group, Application, Gauge Size, Distribution Channel, and Region
By Product Type * Push/Top Button
By Incision Type * Needle
By Age Group * Adult
By Application * Blood Glucose Monitoring
By Gauge Size * 22G and Below
By Distribution Channel * Hospital Pharmacies
By Region * North America (By Product Type, Incision Type, Age Group, Application, Gauge Size, Distribution Channel, and Country)